Contact
Linkedin
Twitter
Youtube
RSS
LANGUAGES
English
Français
Presentation
About Adocia
Founders
Management
Board of Directors
Team
Scientific Advisory Board
Symbol
Technology
BIOCHAPERONE
®
Intellectual property
Publications
Products
Pipeline
BIOCHAPERONE
®
LISPRO
BIOCHAPERONE
®
COMBO
M1Pram
BIOCHAPERONE® GLUCAGON
BIOCHAPERONE® Gla GLP-1
BioChaperone
®
Glucagon GLP-1
Cell Therapy: AdoShell Islets
Partnering
Licensing Opportunities
Contact
Financials
Home Investors
Regulated Information
Documentation
Shareholders
Shareholders meeting
Governance
Investors Contact
Careers
Working at Adocia
HR Policy
Gender Equality index
Offers
News & Events
Press Releases
Upcoming Events
Monday, 09 May 2022
/
Published in
ADOCIA Announces the First Patient Dosed In the BioChaperone® Lispro Phase 3 Program with Partner Tonghua Dongbao
TOP
English 
Français 